Rh-null is a rare and unique blood type, often referred to as 'Golden Blood'. This blood type is found in less than 50 people ...
Access to ERS Genomics’ foundational CRISPR/Cas9 patent portfolio expands our genetic engineering toolkit and strengthens our ability to speed up and optimize strain development across Dyadic’s ...
The real revolution came in 2012, when researchers Jennifer Doudna and Emmanuelle Charpentier harnessed CRISPR, a natural bacterial defense system. In bacteria, CRISPR cuts out invading viruses’ DNA ...
ERS Genomics Limited ('ERS'), the CRISPR licensing company, and Dyadic Applied BioSolutions ('Dyadic'), a global biotechnology ...
ERS Genomics Limited ('ERS'), the CRISPR licensing company, and Dyadic Applied BioSolutions, a global biotechnology company producing precision-engineered ...
Detailed price information for Crispr Therapeutics Ag (CRSP-Q) from The Globe and Mail including charting and trades.
Explore CRISPR technology explained, gene editing science, DNA modification, and genetic engineering ethics—discover how ...
Ecuadorian scientists have, for the first time, edited the gene of a fungus that destroys banana plantations. Using an ...
Only one in every six million people have the Rh null blood type. Now researchers are trying to grow it in the laboratory in ...
A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes towards the controversial approach.
One person’s side effect could be another person’s treatment if we expand our perspective on small molecule drug targets, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback